HK Stock Market Move | CRRC Corporation (01766) rose over 4%, with a year-on-year increase of 10.28% in net profit attributable to shareholders in the first half of the year. The company's overseas business continues to advance.
China CNR Corporation (01766) rose over 4%. As of the time of writing, it is up 3.7%, trading at HKD 5.33, with a trading volume of HKD 128 million.
CRRC Corporation (01766) rose by over 4%, and as of the time of writing, it was up 3.7%, priced at HKD 5.33, with a trading volume of HKD 128 million.
On August 19, CRRC Corporation announced its mid-year results for 2026, reporting an operating income of approximately RMB 131.682 billion, a year-on-year increase of 9.96%; the net profit attributable to shareholders of the listed company was approximately RMB 7.99 billion, up 10.28% year-on-year; the basic earnings per share were RMB 0.28, with a proposed cash dividend of RMB 0.11 per share (before tax). The announcement stated that the revenue growth was mainly due to increased income from railway equipment and Shenzhen New Industries Biomedical Engineering.
Soochow pointed out that the company's operating income from other countries or regions in the first half of 2026 was RMB 16.204 billion, a year-on-year increase of 22.44%; the rail transit equipment business continues to expand in regions such as Central Asia, Latin America, Southeast Asia, and Africa, while the full lifecycle system solutions (DLS) business further expands into Oceania, and the ongoing development of overseas operations is expected to support the company's international growth.
Related Articles

HK Stock Market Move | LEADS BIOLABS-B (09887) surged over 10% in the afternoon, and the summary of Wealthy Trust WCLC has been published, securing a global license for three antibodies with a $10 million deal.

Lyon: Upgrades Hong Kong Stock Exchange (00388) target price to HKD 540; expansion into new asset classes becomes the key to revaluation.

JP Morgan: Lowers target price for CHINA RES BEER (00291) to HK$28, maintains "Overweight" rating.
HK Stock Market Move | LEADS BIOLABS-B (09887) surged over 10% in the afternoon, and the summary of Wealthy Trust WCLC has been published, securing a global license for three antibodies with a $10 million deal.

Lyon: Upgrades Hong Kong Stock Exchange (00388) target price to HKD 540; expansion into new asset classes becomes the key to revaluation.

JP Morgan: Lowers target price for CHINA RES BEER (00291) to HK$28, maintains "Overweight" rating.

RECOMMEND





